Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Seventh generation bonding agents for dentin hypersensitivity
NCT04225247Phase 3Completed
- Sponsor
- Dow University of Health Sciences
- Start
- Mar 2018
- Primary completion
- Oct 2018
- Modality
- Small Molecules, Device-based Delivery
- Countries
- 1
01
Overview
A Phase 3 trial of 3M Single Bond Universal in dentin hypersensitivity (DH), sponsored by Dow University of Health Sciences. Started Mar 2018; status: completed.
02
Drugs
3M Single Bond Universal
03
Conditions
dentin hypersensitivity (DH)
Beyond the preview
Go deeper on NCT04225247.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04225247.